Leadership Transition - Dentsply Sirona has appointed Daniel Scavilla as President and CEO, effective August 1, 2025, succeeding Simon Campion who will leave the company on July 31, 2025 [1][3] - Scavilla has over three decades of experience in the medical technology and pharmaceutical industries, previously serving as CEO of Globus Medical and holding various leadership roles at Johnson & Johnson [2][8] - The Board of Directors expresses confidence in Scavilla's ability to enhance shareholder value and lead the company through its transformation [3] Financial Performance - Dentsply Sirona expects to report second quarter 2025 net sales of approximately $935 million, with adjusted earnings per diluted share anticipated to be between $0.50 and $0.52 [5] - The company reaffirmed its 2025 outlook as provided in the May 8, 2025 earnings press release, indicating ongoing confidence in its financial trajectory [6] Company Overview - Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with a strong portfolio of brands and a commitment to innovation in dental care [9]

Core Insights - VB Spine has successfully acquired the U.S. spine business from Stryker and will operate as a standalone entity [1] - The company is advancing towards completing the acquisition of Stryker's international spine businesses, pending legal and regulatory requirements [2] - VB Spine aims to enhance patient outcomes through innovative technology solutions and a strong focus on operational excellence [3][4] Company Overview - VB Spine is the largest privately held spine company and among the largest family-owned medical technology companies globally, emphasizing patient outcomes [8] - The company has access to Stryker's Mako Spine and Copilot, which will support its growth and improve surgical precision [6] - VB Spine is led by the Viscogliosi Brothers, who have a history of innovation in spine technology [5][8] Strategic Goals - VB Spine is committed to addressing critical needs in spine surgery and enhancing patient care through a comprehensive product portfolio and strong distribution network [3][8] - The company plans to continue its growth strategy by completing additional phases of the acquisition in international markets [5] - VB Spine's value proposition includes specialized solutions that empower surgeons and improve patient outcomes [3][6]

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE: SYK). The business will operate as a standalone company under the na ...